Beranda › Leukemia › Wisconsin › Milwaukee
Uji klinis Leukemia di Milwaukee, WI
11 studi untuk Leukemia mencari peserta di lokasi sekitar Milwaukee (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Menerima pesertaStudi observasional
- Children's Hospital of Wisconsin, Milwaukee
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Menerima pesertaFase 3
- Froedtert & Medical College of Wisconsin, Milwaukee
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Menerima pesertaFase 1
- Froedtert & Medical College Clinics, Milwaukee
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
Menerima pesertaFase 1/2
- Research Site, Milwaukee
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
Menerima pesertaStudi observasional
- Children's Hospital of Wisconsin, Milwaukee
MCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing
Menerima peserta
- Children's Wisconsin, Milwaukee
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
Menerima pesertaFase 2/3
- Froedtert & Medical College of Wisconsin, Milwaukee
Anti-CD30 biAb-AATC in Patients With Relapsed/Refractory CD30 Positive Hematopoietic Malignancies
Menerima pesertaFase 1
- Froedtert & the Medical College of Wisconsin, Milwaukee
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Menerima pesertaFase 1
- Medical College of Wisconsin Cancer Center, Milwaukee
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Menerima pesertaStudi observasional
- Massive Bio SYNERGY-AI site, Milwaukee
Post-authorization Safety Study of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Treated With Mogamulizumab
Menerima pesertaStudi observasional
- CIBMTR, Milwaukee
Uji klinis Leukemia di kota lain
- Houston, TX28 studi
- Boston, MA25 studi
- New York City, NY19 studi
- Los Angeles, CA16 studi
- Chicago, IL16 studi
- Durham, NC13 studi
- Baldwin Park, CA12 studi
- Columbus, OH12 studi
- Nashville, TN12 studi
- Philadelphia, PA12 studi
- Atlanta, GA11 studi
- Seattle, WA11 studi
Studi lain di Milwaukee
- Kanker Payudara23 studi
- Kanker Paru Non-Sel Kecil22 studi
- Kanker (semua jenis)22 studi
- Kanker Paru21 studi
- Mieloma Multipel21 studi
- Kanker Prostat20 studi
- Limfoma Folikuler19 studi
- Kanker Pankreas18 studi
- Limfoma Non-Hodgkin18 studi
- Kanker Ovarium17 studi
- Leukemia Mieloid Akut17 studi
- Limfoma Burkitt16 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.